• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on the Emerging Growth Conference 77 Day 2 on December 5th Register Now

    12/4/24 7:00:00 AM ET
    $AEMD
    $ASPI
    $ATRA
    $BENF
    Medical/Dental Instruments
    Health Care
    Major Chemicals
    Industrials
    Get the next $AEMD alert in real time by email

    MIAMI, Dec. 04, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 77th Emerging Growth Conference on December 4 & 5, 2024.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter.



    Day 1


    December 4, 2024

    9:00

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:35

    Introduction

    9:40 – 10:10

    ATRenew Inc. (NYSE:RERE) 

    Keynote speakers: Jessie Jin, Investor Relations Manager, & Jeremy Ji, Director of Corporate Development & Investor Relations

    10:15 – 10:45

    Beneficient (NASDAQ:BENF)

    Keynote speaker: Brad K. Heppner, CEO

    10:50 - 11:20

    U.S. Energy Corporation (NASDAQ:USEG)

    Keynote speaker: Ryan Smith, President, CEO & Director

    11:25 - 11:55

    Brenmiller Energy, Ltd. (NASDAQ:BNRG)

    Keynote speaker: Nir Brenmiller, COO

    12:00 – 12:30

    West Red Lake Gold Mines Ltd. (OTCQB:WRLGF) (TSXV:WRLG)

    Keynote speaker: Gwen Preston, Vice President, Communications

    12:35 - 1:05

    Eloro Resources, Ltd. (OTCQX:ELRRF) (TSX:ELO)

    Keynote speakers: Thomas Larsen, CEO & Chairman, & Dr. William N. Pearson, Executive Vice President of Exploration

    1:10 - 1:40

    Luca Mining (OTCQX:LUCMF) (TSXV:LUCA)

    Keynote speaker: Dan Barnholden, CEO

    2:40 – 2:50

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO, & Harry M. Lander, Ph.D. Senior Scientific Consultant

    2:55 – 3:05

    Viomi Technology Co., Ltd. (NASDAQ:VIOT)

    Keynote speakers: Claire Ji – IR & Finance, and Sam Yang, Head of Capital and Strategy

    3:10 – 3:20

    Realbotix Corp. (OTCQB:XBOTF) (TSXV:XBOT)

    Keynote speaker: Andrew Kiguel Co-Founder, CEO

    3:25 - 3:35

    Icon Energy Corp. (NASDAQ:ICON)

    Keynote speakers: Ismini Evangelia Panagiotidi, CEO, Chairwoman & Dennis Psachos, CFO

    3:40 – 3:50

    NurExone Biologic Inc. (OTCQB:NRXBF) (TSXV:NRX)

    Keynote speaker: Dr. Lior Shaltiel, CEO

    3:55 – 4:05

    Pure Cycle Corporation (NASDAQ:PCYO) 

    Keynote speaker: Mark Harding, President

    4:10 – 4:20

    MetaVia, Inc. (NASDAQ:MTVA)

    Keynote speakers: Hyung Heon "HH" Kim, President / CEO, & Marshall H. Woodworth, CFO

    4:25 – 4:35

    Aethlon Medical, Inc. (NASDAQ:AEMD)

    Keynote speakers: Jim Frakes, Acting CEO and CFO & Steven LaRosa, Chief Medical Officer

    4:40 – 4:50

    Sky Harbour Group Corporation (NYSE:SKYH)

    Keynote speakers: Tal Keinan, Founder and CEO & Francisco X. Gonzalez, CFO



    Day 2


    December 5, 2024

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    U Power Limited (NASDAQ:UCAR)

    Keynote speaker: Paul Li – UCAR European Representative

    9:40 – 10:10

    BioVaxys Technology Corp. (OTCQB:BVAXF) (CSE:BIOV)

    Keynote speaker: James Passin, CEO

    10:15 – 10:45

    ASP Isotopes Inc. (NASDAQ:ASPI)

    Keynote speaker: Paul Elliot Mann, CEO

    10:50 - 11:20

    Jaguar Health, Inc. (NASDAQ:JAGX)

    Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director

    11:25 - 11:55

    Windtree Therapeutics, Inc. (NASDAQ:WINT)

    Keynote speaker: Craig Fraser, President & CEO

      

    12:00 - 12:30

    Longeveron, Inc. (NASDAQ:LGVN)

    Keynote speaker: Mohamed Wa'el Hashad, CEO & Director

    12:35 - 1:05

    Bioxytran, Inc. (OTCQB:BIXT)

    Keynote speakers: David Platt, CEO & Mike Sheikh, Executive Vice President Business Development

    1:10 - 1:40

    Nova Minerals Limited (NASDAQ:NVA) (OTC:NVAAF) (ASX: NVA)

    Keynote speaker: Christopher Gerteisen – CEO & Executive Director

    1:45 - 2:15

    Innovotech, Inc. (TSXV:IOT)

    Keynote speaker: Craig Milne, CEO

    2:55 – 3:05

    Stuhini Explorations, Ltd. (OTCQB:STXPF) (TSXV:STU)

    Keynote speaker: David O'Brien, President & CEO

    3:10 - 3:20

    Atara Biotherapeutics, Inc. (NASDAQ:ATRA)

    Keynote speaker: Jason Awe, Head of Corporate Communications & IR

    3:25 - 3:35

    Vista Gold Corp. (NYSE:VGZ) (TSX:VGZ)

    Keynote speaker: Frederick Earnest – CEO

    3:40 – 3:50

    Interstellar Communication Holdings 

    Keynote speakers: Seda Hewitt, Space Ambassador of IcMercury Harri Laitinen, Lifeguard  of IcMercury, and Lijie Zhu, Captain of icMercury

    3:55 – 4:20

    Cannabis Bioscience International Holdings Inc. (OTC:CBIH)

    Keynote speakers: Dante Picaso, President / CEO

    4:25 – 4:55

    Opawica Explorations Inc. (OTCQB:OPWEF) (TSXV:OPW)

    Keynote speaker: Blake Morgan, President / CEO

    Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $AEMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • When is the Emerging Growth Conference scheduled to occur?

      The conference will take place on December 4 and 5, 2024.

    • What is the purpose of the Emerging Growth Conference?

      The Emerging Growth Conference focuses on identifying companies in various growth sectors that exhibit strong management, innovative products, and a focus on long-term growth potential.

    • How can attendees register for the Emerging Growth Conference?

      Participants can register for the conference by clicking the provided registration link. There is an option for those who have already registered to enter their email to confirm their registration.

    • How can attendees ask questions to the presenting companies?

      Attendees can submit questions for any of the presenting companies by sending an email to [email protected].

    • What is the background of EmergingGrowth.com?

      EmergingGrowth.com was founded in 2009 and specializes in identifying emerging growth companies that may be overlooked by the investment community.

    Recent Analyst Ratings for
    $AEMD
    $ASPI
    $ATRA
    $BENF

    CompanyDatePrice TargetRatingAnalyst
    Atara Biotherapeutics Inc.
    $ATRA
    1/13/2026$6.00Buy → Hold
    Canaccord Genuity
    ASP Isotopes Inc.
    $ASPI
    12/4/2025$13.00Overweight
    Cantor Fitzgerald
    Sky Harbour Group Corporation
    $SKYH
    10/27/2025$13.00Buy
    BTIG Research
    MetaVia Inc.
    $MTVA
    9/4/2025$12.00Buy
    H.C. Wainwright
    Aethlon Medical Inc.
    $AEMD
    7/7/2025$1.50Neutral
    H.C. Wainwright
    Sky Harbour Group Corporation
    $SKYH
    6/9/2025$14.00Buy
    Lake Street
    Sky Harbour Group Corporation
    $SKYH
    5/12/2025$23.00Outperform
    Noble Capital Markets
    Sky Harbour Group Corporation
    $SKYH
    4/25/2025$14.50Buy
    Alliance Global Partners
    More analyst ratings

    $AEMD
    $ASPI
    $ATRA
    $BENF
    SEC Filings

    View All

    Longeveron Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Longeveron Inc. (0001721484) (Filer)

    2/13/26 4:45:34 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Brenmiller Energy Ltd

    6-K - Brenmiller Energy Ltd. (0001901215) (Filer)

    2/13/26 4:05:02 PM ET
    $BNRG
    Building Products
    Industrials

    SEC Form 10-Q filed by Aethlon Medical Inc.

    10-Q - AETHLON MEDICAL INC (0000882291) (Filer)

    2/12/26 5:10:41 PM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    $AEMD
    $ASPI
    $ATRA
    $BENF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Smith Ryan Lewis bought $4,560 worth of shares (4,000 units at $1.14), increasing direct ownership by 0.34% to 1,183,039 units (SEC Form 4)

    4 - US ENERGY CORP (0000101594) (Issuer)

    9/15/25 7:00:12 AM ET
    $USEG
    Oil & Gas Production
    Energy

    Large owner Panacea Innovation Ltd bought $670,422 worth of shares (55,000 units at $12.19) (SEC Form 4)

    4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)

    8/19/25 8:15:04 PM ET
    $ATRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CEO Smith Ryan Lewis bought $2,340 worth of shares (2,000 units at $1.17), increasing direct ownership by 0.17% to 1,179,039 units (SEC Form 4)

    4 - US ENERGY CORP (0000101594) (Issuer)

    8/14/25 7:00:13 AM ET
    $USEG
    Oil & Gas Production
    Energy

    $AEMD
    $ASPI
    $ATRA
    $BENF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Longeveron® Appoints Stephen H. Willard as Chief Executive Officer

    Mr. Willard has a 30+ year track record of leadership across public and private sectors as CEO of multiple biotechnology and pharmaceutical firms, with an impressive history of delivering significant fundraises and strategic collaborationsCorporate focus on delivering top-line results from the pivotal Phase 2b clinical trial in Hypoplastic Left Heart Syndrome (HLHS), anticipated in the third quarter of 2026 Than Powell stepped down as interim CEO; will remain with the Company to support the leadership transition and continue his work in the Company's on-going business development activities MIAMI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage regenerati

    2/13/26 4:30:00 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    U Power to Present at OTC Markets AI & Technology Investor Conference on February 19

    BANGKOK, Feb. 13, 2026 /PRNewswire/ -- U Power Limited (NASDAQ:UCAR) ("U Power" or the "Company"), a provider of AI-integrated solutions for next-generation energy grids and intelligent transportation systems, today announced that its management team will present at the OTC Markets AI & Technology Investor Conference on February 19, and host one-on-one meetings with investors from February 19-24, 2026. U Power's main presentation is scheduled for Thursday, February 19 at 11:00 am ET. Investors can access the live presentation via: Virtual Investor Conference Management will also host virtual one-on-one meetings with investors during February 19-20, and February 23-24. Investors can request

    2/13/26 12:00:00 PM ET
    $UCAR
    Auto Parts:O.E.M.
    Consumer Discretionary

    MetaVia Builds Comprehensive Global Patent Protection for DA-1726, Securing Exclusive Rights to Novel Obesity and Metabolic Therapy Through 2041

    Intellectual Property Portfolio Includes 39 Granted and Pending Patents in the U.S. and Internationally, Providing Protection Into 2041, Unless Extended Further CAMBRIDGE, Mass., Feb. 13, 2026 /PRNewswire/ -- MetaVia Inc. (NASDAQ:MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a strong global intellectual property portfolio supporting lead asset DA-1726, a novel, dual oxyntomodulin (OXM) analog agonist that functions as a glucagon-like peptide-1 receptor (GLP1R) and glucagon receptor (GCGR), for the treatment of obesity and related metabolic disorders. This currently includes 39 granted and pending patents in the U.S. and intern

    2/13/26 8:31:00 AM ET
    $MTVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEMD
    $ASPI
    $ATRA
    $BENF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Atara Biotherapeutics downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Atara Biotherapeutics from Buy to Hold and set a new price target of $6.00

    1/13/26 10:16:38 AM ET
    $ATRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Cantor Fitzgerald initiated coverage on ASP Isotopes with a new price target

    Cantor Fitzgerald initiated coverage of ASP Isotopes with a rating of Overweight and set a new price target of $13.00

    12/4/25 8:40:44 AM ET
    $ASPI
    Major Chemicals
    Industrials

    BTIG Research initiated coverage on Sky Harbour with a new price target

    BTIG Research initiated coverage of Sky Harbour with a rating of Buy and set a new price target of $13.00

    10/27/25 8:48:57 AM ET
    $SKYH
    Real Estate
    Finance

    $AEMD
    $ASPI
    $ATRA
    $BENF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 5 filed by Batchelor Joshua Lane

    5 - US ENERGY CORP (0000101594) (Issuer)

    2/12/26 12:58:02 PM ET
    $USEG
    Oil & Gas Production
    Energy

    Chief Financial Officer Woodworth Marshall H was granted 28,000 shares, increasing direct ownership by 1,024% to 30,734 units (SEC Form 4)

    4 - MetaVia Inc. (0001638287) (Issuer)

    1/27/26 4:02:10 PM ET
    $MTVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO & President Kim Hyung Heon was granted 32,000 shares, increasing direct ownership by 577% to 37,545 units (SEC Form 4)

    4 - MetaVia Inc. (0001638287) (Issuer)

    1/27/26 4:01:16 PM ET
    $MTVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEMD
    $ASPI
    $ATRA
    $BENF
    Leadership Updates

    Live Leadership Updates

    View All

    Longeveron® Appoints Stephen H. Willard as Chief Executive Officer

    Mr. Willard has a 30+ year track record of leadership across public and private sectors as CEO of multiple biotechnology and pharmaceutical firms, with an impressive history of delivering significant fundraises and strategic collaborationsCorporate focus on delivering top-line results from the pivotal Phase 2b clinical trial in Hypoplastic Left Heart Syndrome (HLHS), anticipated in the third quarter of 2026 Than Powell stepped down as interim CEO; will remain with the Company to support the leadership transition and continue his work in the Company's on-going business development activities MIAMI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage regenerati

    2/13/26 4:30:00 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Pure Cycle Corporation Appoints Daniel J. Roller to its Board of Directors

    DENVER, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Pure Cycle Corporation (NASDAQ Capital Market: PCYO) ("Pure Cycle", "we", "us" or "our") announced that a new independent director, Daniel J. Roller, was appointed to its Board of Directors (the "Board"), effective January 14, 2026, expanding the Board from 7 to 8 directors. This appointment, made in cooperation with Maran Capital Management, LLC ("Maran"), which beneficially owns approximately 14.7% of Pure Cycle's common shares, further strengthens the Board and adds new skillsets and capabilities. In connection with this appointment, the Board will form a Strategy and Capital Allocation Committee, to be chaired by Mr. Roller. Mr. Roller, Presid

    1/15/26 8:30:00 AM ET
    $PCYO
    Water Supply
    Utilities

    Beneficient Appoints Peter T. Cangany Jr. as Chairman of the Board

    DALLAS, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced that its Board of Directors (the "Board") has appointed Peter T. Cangany Jr. as Chairman of the Board, effective December 15, 2025. Mr. Cangany has served as a director of Beneficient and as Chairman of its independent Audit Committee since 2019. He brings decades of leadership experience in financial reporting, accounting, and corporate governance within the financial services industry. Mr. Cangany retired as a partner

    12/17/25 7:30:00 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    $AEMD
    $ASPI
    $ATRA
    $BENF
    Financials

    Live finance-specific insights

    View All

    Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update

    Clinical and research programs continue to advance, supported by year-to-date cost efficiencies Conference Call Today at 4:30 p.m. ET SAN DIEGO, Feb. 12, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal third quarter ended December 31, 2025, and provided an update on recent developments.  Key Highlights Maintained Nasdaq Listing: Continued compliance with Nasdaq listing requirements, with all prior compliance matters remaining resolved. Clinical Progress: Cohort 2 of the Australian oncology tr

    2/12/26 4:15:00 PM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026

    SAN DIEGO, Feb. 4, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal third quarter ended December 31, 2025, at 4:15 p.m. ET on Thursday, February 12, 2026. Management will host a conference call on Thursday, February 12, 2026, at 4:30 p.m. ET to review financial results and recent corporate developments. Following management's formal remarks, there will be a question and answer session. Interested parties can register for the conference call by navigating to https://dpregister.com/sreg/10206585/1034

    2/4/26 8:01:00 AM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel)

    U.S. Food and Drug Administration has issued a Complete Response Letter (CRL) Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the EBVALLO™ (tabelecleucel) Biologics License Application (BLA) as monotherapy treatment for adult and pediatric patients two years of age and older with Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD), who have received at least one

    1/12/26 8:00:00 AM ET
    $ATRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AEMD
    $ASPI
    $ATRA
    $BENF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Pure Cycle Corporation

    SC 13D/A - PURE CYCLE CORP (0000276720) (Subject)

    12/5/24 6:15:44 PM ET
    $PCYO
    Water Supply
    Utilities

    Amendment: SEC Form SC 13D/A filed by Brenmiller Energy Ltd

    SC 13D/A - Brenmiller Energy Ltd. (0001901215) (Subject)

    12/5/24 11:18:20 AM ET
    $BNRG
    Building Products
    Industrials

    SEC Form SC 13G filed by Icon Energy Corp.

    SC 13G - Icon Energy Corp (0001995574) (Subject)

    11/14/24 8:38:27 PM ET
    $ICON
    Marine Transportation
    Consumer Discretionary